| 1081/1816 | US=64 / Câncer Yhomas SK, Richards TA, Weber DM. Lenalidomide in relapsed or refractory multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 265-77. (Comtemporary Hematology) ISBN 978-1-934115-82-4. LENALIDOMIDA EM RECIDIVA; MIELOMA MULTIPLO REFRACTARIO; ESTEROIDES; ANTRACICLINAS |
| 1082/1816 | US=64 / Câncer Kumar S. Lenalidomide for initial therapy of newly diagnosed multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 279-88. (Comtemporary Hematology) ISBN 978-1-934115-82-4. LENALIDOMIDA. TERAPIA COM MIELOMA MULTIPLO; MALIGNIDADE HEMATOLOGICA. LINFOMA NAO-HODGKIN |
| 1083/1816 | US=64 / Câncer Mitsiades CS, Hideshima T, Munshi NC, Richardson PG, Anderson KC. The role of heat shock protein 90 as a therapeutic target for multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 291-308. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TERAPEUTICO PARA O MIELOMA MULTIPLO; CHAPERONE MOLECULAR UBIQUAMENTE |
| 1084/1816 | US=64 / Câncer Harvey RD, Silberman J, Lonmial S. The PI3 kinase/akt pathway as a therapeutic target in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 309-22. (Comtemporary Hematology) ISBN 978-1-934115-82-4. PI3 QUINASE; AKT; TERAPEUTICO NO MIELOMA MULTIPLO; MIELOMA MULTIPLO. TERAPIAS |
| 1085/1816 | US=64 / Câncer Frost P, Lichtenstein A. The mammalian target of rapamycin and multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 323-30. (Comtemporary Hematology) ISBN 978-1-934115-82-4. RAPAMICINA EM MAMIFEROS; MIELOMA MULTIPLO; CELULAS EUCARIOTICAS; IMUNO-HISTOQUIMICA |
| 1086/1816 | US=64 / Câncer Dai Y, Grant S. CDK inhibitors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 331-63. (Comtemporary Hematology) ISBN 978-1-934115-82-4. INIBIDORES DE CDK NO MIELOMA MULTIPLO; PROGRESSAO DO CICLO CELULAR; QUINASES DEPENDENTES DE CICLINA |
| 1087/1816 | US=64 / Câncer Jiménez-Zepeda VH, Stewart AK. Fibroblast growth, factor receptor 3 and multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 365-78. (Comtemporary Hematology) ISBN 978-1-934115-82-4. CRESCIMENTO DE FIBROBLASTOS; RECEPTOR DO FACTOR DE 3; MIELOMA MULTIPLO; TRANSLOCACOES CROMOSSOMICAS |
| 1088/1816 | US=64 / Câncer Hideshima T. Histone deacetylase inhibitors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 379-92. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 1089/1816 | US=64 / Câncer Mollinedo F. Death receptors in multiple myeloma and therapeutic opportunities. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 393-419. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 1090/1816 | US=64 / Câncer Chauhan D, Singh A, Anderson K. Proteasome inhibitors as therapy in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 421-32. (Comtemporary Hematology) ISBN 978-1-934115-82-4. TERAPIA EM MIELOMA MULTIPLO. INIBIDORES DE PROTEASSOMA; HOMEOSTASE CELULAR NORMAL; AGENTES ANTICANCERIGENOS. INIBIDORES DE PROTEASSOMA |
| 1091/1816 | US=64 / Câncer Mark TM, Pearse RN. Pathophysiology of bone disease in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 435-54. (Comtemporary Hematology) ISBN 978-1-934115-82-4. DOENCA OSSEA DO MIELOMA MULTIPLO. FISIOPATOLOGIA; MIELOMA MULTIPLO; MALIGNIDADE DE CELULAS PLASMATICAS; CRESCIMENTO DA MEDULA OSSEA |
| 1092/1816 | US=64 / Câncer Sloan MJ, Raje N. Anemia and erythropoietic growth factors in multiple myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 455-68. (Comtemporary Hematology) ISBN 978-1-934115-82-4. ANEMIA; ERITROPOIESE EM MIELOMA MULTIPLO. FATORES DE CRESCIMENTO |
| 1093/1816 | US=64 / Câncer Narayanan S, Tong FC. Percutaneous vertebroplasty and balloon kyphoplasty for the treatment of acute painful pathologic fracture. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 469-89. (Comtemporary Hematology) ISBN 978-1-934115-82-4. VERTEBROPLASTIA PERCUTANEA; CIFOPLASTIA; TRATAMENTO DE FRATURA DOLOROSA |
| 1094/1816 | US=64 / Câncer Durie BGM. The role of anatomic and functional imaging in myeloma. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 491-8. (Comtemporary Hematology) ISBN 978-1-934115-82-4. PAPEL DA IMAGEM ANATOMICA EM MIELOMA; PAPEL DA IMAGEM FUNCIONAL EM MIELOMA |
| 1095/1816 | US=64 / Câncer Ailawadhi S, Chanan-Khan A. Management of multiple myeloma patients with renal dysfunction. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 499-516. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 1096/1816 | US=64 / Câncer Simpson L, Gertz M. Waldenstrom's macroglobulinemia. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 519-50. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 1097/1816 | US=64 / Câncer Sanchorawala V. AL (immunoglobulin light-chain amyloidosis). In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 551-69. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 1098/1816 | US=64 / Câncer Dispenzieri A. POEMS syndrome and other atypical plasma cell disorders. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 571-623. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 1099/1816 | US=64 / Câncer Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance. In: Lonial S. Mylenoma therapy: pursuing the plasma cell. 5th ed. New Jersey: Humana Press, 2008. p. 625-49. (Comtemporary Hematology) ISBN 978-1-934115-82-4. |
| 1100/1816 | US=67 / Biol/Mol Knights CD, Pestell RG. The cell cycle: therapeutic targeting of cell regulatory components and effector pathways in cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 3-32. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CICLO CELULAR; SEGMENTACAO TERAPEUTICA; COMPONENTES CELULARES; VIAS REGULADORAS; CANCER; CICLINA DEPENDENTE DE QUINASE; INIBIDORES CDK; TERAPIA; ACETILACAO; P53; CICLINA D1; EGFR; HDAC; STI-571; FLAVOPIRIDOL; INIBIDOR CDK2 |